ReviewAbdominal radiology (New York)2025
Contrast-enhanced ultrasound in pregnancy.
Review in Abdominal radiology (New York), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Standardizing Safety Practices for Contrast-Enhanced Ultrasound in Radiology.Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
There are complex problems related to diagnostic imaging of the pregnant patient Cross sectional imaging with computed tomography (CT) tends to be avoided to due to the risk radiation poses to the fetus and magnetic resonance imaging (MRI) may be limited due to avoidance of gadolinium contrast.While ultrasound (US) is the primary test for imaging in pregnancy, there is limited awareness of contrast-enhanced US (CEUS) as a safe and accurate option for providing similar vascular information to that which is usually provided with contrast-enhanced CT and MRI. Microbubble contrast agents do not cross the placental barrier and have been shown in animal studies to pose no harm to the fetus at doses far above the human dose.The literature on CEUS in pregnancy will be reviewed and the utility and diagnostic accuracy of CEUS for the assessment of acute and chronic maternal conditions and evaluation of neoplastic masses will be demonstrated with case examples.
Indexed as
Identifiers
40126608What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.